Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gaia Medical Institute develops noninvasive, saliva-based point-of-care diagnostic tests focused on rapid identification of concussion/TBI and dementia. Their IP-protected technology enables decentralized testing using lateral flow immunoassays to detect proteomic biomarkers in saliva. The company also researches diagnostics for HIV/AIDS, hydration status, PTSD, heart failure, chemotherapy-induced neuropathy, influenza, and more. Clinical results are not published but the technology aims to fill unmet needs in rapid brain health assessment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gaia Medical Institute.